1
|
Trimaglio G, Sneperger T, Raymond BBA, Gilles N, Näser E, Locard-Paulet M, Ijsselsteijn ME, Brouwer TP, Ecalard R, Roelands J, Matsumoto N, Colom A, Habch M, de Miranda NFCC, Vergnolle N, Devaud C, Neyrolles O, Rombouts Y. The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer. Sci Rep 2024; 14:7199. [PMID: 38532110 DOI: 10.1038/s41598-024-57941-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Accepted: 03/22/2024] [Indexed: 03/28/2024] Open
Abstract
Development and progression of malignancies are accompanied and influenced by alterations in the surrounding immune microenvironment. Understanding the cellular and molecular interactions between immune cells and cancer cells has not only provided important fundamental insights into the disease, but has also led to the development of new immunotherapies. The C-type lectin Dendritic Cell ImmunoReceptor (DCIR) is primarily expressed by myeloid cells and is an important regulator of immune homeostasis, as demonstrated in various autoimmune, infectious and inflammatory contexts. Yet, the impact of DCIR on cancer development remains largely unknown. Analysis of available transcriptomic data of colorectal cancer (CRC) patients revealed that high DCIR gene expression is associated with improved patients' survival, immunologically "hot" tumors and high immunologic constant of rejection, thus arguing for a protective and immunoregulatory role of DCIR in CRC. In line with these correlative data, we found that deficiency of DCIR1, the murine homologue of human DCIR, leads to the development of significantly larger tumors in an orthotopic murine model of CRC. This phenotype is accompanied by an altered phenotype of tumor-associated macrophages (TAMs) and a reduction in the percentage of activated effector CD4+ and CD8+ T cells in CRC tumors of DCIR1-deficient mice. Overall, our results show that DCIR promotes antitumor immunity in CRC, making it an attractive target for the future development of immunotherapies to fight the second deadliest cancer in the world.
Collapse
Affiliation(s)
- Giulia Trimaglio
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Tamara Sneperger
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Benjamin B A Raymond
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Nelly Gilles
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Emmanuelle Näser
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Marie Locard-Paulet
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | | | - Thomas P Brouwer
- Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
| | - Romain Ecalard
- INSERM US006 ANEXPLO/CREFRE, Purpan Hospital, Toulouse, France
| | - Jessica Roelands
- Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
| | - Naoki Matsumoto
- Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan
| | - André Colom
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Myriam Habch
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | | | - Nathalie Vergnolle
- Institut de Recherche en Santé Digestive, IRSD, Université de Toulouse, INSERM, INRAe, ENVT, UPS, Toulouse, France
| | - Christel Devaud
- Institut de Recherche en Santé Digestive, IRSD, Université de Toulouse, INSERM, INRAe, ENVT, UPS, Toulouse, France
| | - Olivier Neyrolles
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Yoann Rombouts
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
| |
Collapse
|
2
|
Rombouts Y, Neyrolles O. The fat is in the lysosome: how Mycobacterium tuberculosis tricks macrophages into storing lipids. J Clin Invest 2023; 133:168366. [PMID: 36919697 PMCID: PMC10014092 DOI: 10.1172/jci168366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
Abstract
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), infects primarily macrophages, causing them to differentiate into lipid-laden foamy macrophages that are a primary source of tissue destruction in patients with TB. In this issue of the JCI, Bedard et al. demonstrate that 1-tuberculosinyladenosine, a virulence factor produced by M. tuberculosis, caused lysosomal dysfunction associated with lipid storage in the phagolysosome of macrophages in a manner that mimicked lysosomal storage diseases. This work sheds light on how M. tuberculosis manipulates host lipid metabolism for its survival and opens avenues toward host-directed therapy against TB.
Collapse
|
3
|
Bellini R, Moregola A, Nour J, Rombouts Y, Neyrolles O, Uboldi P, Bonacina F, Norata GD. Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression. Atherosclerosis Plus 2022; 51:8-12. [PMID: 36969702 PMCID: PMC10037088 DOI: 10.1016/j.athplu.2022.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Revised: 11/22/2022] [Accepted: 12/14/2022] [Indexed: 12/23/2022]
Abstract
Background and aims Atherogenesis results from altered lipid metabolism and impaired immune response. Emerging evidence has suggested that dendritic cells (DCs) participate to atherosclerosis-related immune response, but their impact is scarcely characterized. Clec4a4 or DCIR2 (Dendritic cell immunoreceptor 2) is a C-type lectin receptor, mainly expressed by CD8α- DCs, able to modulate T cell immunity. However, whether this DC subset could play a role in the atherogenesis is still poorly understood. Thus, the aim of this study is to investigate whether the absence of Clec4a4 could affect atherosclerosis-related immune response and atherosclerosis itself. Methods Dcir2 -/- Ldlr -/- and Ldlr -/- mice were fed a standard diet or cholesterol-enriched diet for 12 weeks. Subsequently, the profile of circulating and lymph nodes-resident immune cells was investigated together with the analysis of plasma lipid levels and atherosclerotic plaque extension in the aorta. Results Here, we show that Clec4a4 expression is downregulated under hypercholesterolemia and its deficiency in Ldlr -/- mice results in the reduction of atherosclerotic plaque formation, together with altered lipid metabolism and impaired myeloid immune cell distribution. Conclusions Our findings suggest a pro-atherosclerotic role of Clec4a4 in experimental atherosclerosis.
Collapse
Affiliation(s)
- Rossella Bellini
- Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
| | - Annalisa Moregola
- Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
| | - Jasmine Nour
- Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
| | - Yoann Rombouts
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Olivier Neyrolles
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Patrizia Uboldi
- Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
| | - Fabrizia Bonacina
- Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
| | - Giuseppe Danilo Norata
- Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
- Centro SISA per lo Studio dell’Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Italy
- Corresponding author. Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.
| |
Collapse
|
4
|
Planès R, Pinilla M, Santoni K, Hessel A, Passemar C, Lay K, Paillette P, Valadão ALC, Robinson KS, Bastard P, Lam N, Fadrique R, Rossi I, Pericat D, Bagayoko S, Leon-Icaza SA, Rombouts Y, Perouzel E, Tiraby M, Zhang Q, Cicuta P, Jouanguy E, Neyrolles O, Bryant CE, Floto AR, Goujon C, Lei FZ, Martin-Blondel G, Silva S, Casanova JL, Cougoule C, Reversade B, Marcoux J, Ravet E, Meunier E. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. Mol Cell 2022; 82:2385-2400.e9. [PMID: 35594856 PMCID: PMC9108100 DOI: 10.1016/j.molcel.2022.04.033] [Citation(s) in RCA: 44] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Revised: 02/16/2022] [Accepted: 04/25/2022] [Indexed: 11/30/2022]
Affiliation(s)
- Rémi Planès
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France; InvivoGen, Toulouse, France; IRIM, University of Montpellier, CNRS, Montpellier, France.
| | - Miriam Pinilla
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France; InvivoGen, Toulouse, France
| | - Karin Santoni
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Audrey Hessel
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Charlotte Passemar
- Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK
| | - Kenneth Lay
- Institute of Medical Biology, Agency of Science, Technology and Research, 8A Biomedical Grove, #06-06 Immunos, 138648 Singapore, Singapore; Laboratory of Human Genetics and Therapeutics, Genome Institute of Singapore (GIS), A(∗)STAR, Singapore, Singapore
| | | | | | - Kim Samirah Robinson
- A(∗)STAR Skin Research Laboratories, 11 Mandalay Road, 308232 Singapore, Singapore
| | - Paul Bastard
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
| | - Nathaniel Lam
- University of Cambridge, Department of Veterinary Medicine, Cambridge CB30ES, UK; University of Cambridge, School of Clinical Medicine, Box 111, Cambridge Biomedical Campus, Cambridge CB2 0SP, UK
| | - Ricardo Fadrique
- Biological and Soft Systems, Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge CB3 0HE, UK
| | - Ida Rossi
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - David Pericat
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Salimata Bagayoko
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Stephen Adonai Leon-Icaza
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Yoann Rombouts
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | | | | | - Qian Zhang
- University of Paris, Imagine Institute, Paris, France
| | - Pietro Cicuta
- Biological and Soft Systems, Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge CB3 0HE, UK
| | - Emmanuelle Jouanguy
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
| | - Olivier Neyrolles
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Clare E Bryant
- University of Cambridge, Department of Veterinary Medicine, Cambridge CB30ES, UK; University of Cambridge, School of Clinical Medicine, Box 111, Cambridge Biomedical Campus, Cambridge CB2 0SP, UK
| | - Andres R Floto
- Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK
| | | | - Franklin Zhong Lei
- A(∗)STAR Skin Research Laboratories, 11 Mandalay Road, 308232 Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, 308232 Singapore, Singapore; Skin Research Institute of Singapore (SRIS), 11 Mandalay Road, 308232 Singapore, Singapore
| | - Guillaume Martin-Blondel
- Service des Maladies Infectieuses et Tropicales, CHU de Toulouse, Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France
| | - Stein Silva
- Critical Care Unit, University Hospital of Purpan, Toulouse, France
| | - Jean-Laurent Casanova
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA; Howard Hughes Medical Institute, New York, NY, USA
| | - Céline Cougoule
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Bruno Reversade
- Institute of Medical Biology, Agency of Science, Technology and Research, 8A Biomedical Grove, #06-06 Immunos, 138648 Singapore, Singapore; Laboratory of Human Genetics and Therapeutics, Genome Institute of Singapore (GIS), A(∗)STAR, Singapore, Singapore; Institute of Molecular and Cell Biology, 61 Biopolis Drive, 138673 Singapore, Singapore; Department of Paediatrics, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, 10 Medical Drive, 117597 Singapore, Singapore; The Medical Genetics Department, Koç University School of Medicine, 34010 Istanbul, Turkey
| | - Julien Marcoux
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | | | - Etienne Meunier
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
| |
Collapse
|
5
|
Bagayoko S, Leon-Icaza SA, Pinilla M, Hessel A, Santoni K, Péricat D, Bordignon PJ, Moreau F, Eren E, Boyancé A, Naser E, Lefèvre L, Berrone C, Iakobachvili N, Metais A, Rombouts Y, Lugo-Villarino G, Coste A, Attrée I, Frank DW, Clevers H, Peters PJ, Cougoule C, Planès R, Meunier E. Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology. PLoS Pathog 2021; 17:e1009927. [PMID: 34516571 PMCID: PMC8460005 DOI: 10.1371/journal.ppat.1009927] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Revised: 09/23/2021] [Accepted: 08/29/2021] [Indexed: 11/20/2022] Open
Abstract
Regulated cell necrosis supports immune and anti-infectious strategies of the body; however, dysregulation of these processes drives pathological organ damage. Pseudomonas aeruginosa expresses a phospholipase, ExoU that triggers pathological host cell necrosis through a poorly characterized pathway. Here, we investigated the molecular and cellular mechanisms of ExoU-mediated necrosis. We show that cellular peroxidised phospholipids enhance ExoU phospholipase activity, which drives necrosis of immune and non-immune cells. Conversely, both the endogenous lipid peroxidation regulator GPX4 and the pharmacological inhibition of lipid peroxidation delay ExoU-dependent cell necrosis and improve bacterial elimination in vitro and in vivo. Our findings also pertain to the ExoU-related phospholipase from the bacterial pathogen Burkholderia thailandensis, suggesting that exploitation of peroxidised phospholipids might be a conserved virulence mechanism among various microbial phospholipases. Overall, our results identify an original lipid peroxidation-based virulence mechanism as a strong contributor of microbial phospholipase-driven pathology.
Collapse
Affiliation(s)
- Salimata Bagayoko
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Stephen Adonai Leon-Icaza
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Miriam Pinilla
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Audrey Hessel
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Karin Santoni
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - David Péricat
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Pierre-Jean Bordignon
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Flavie Moreau
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
- Level 3 Biosafety Animal Core facility, Anexplo platform, Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Elif Eren
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Aurélien Boyancé
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Emmanuelle Naser
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
- Cytometry & Imaging Core facility, Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Lise Lefèvre
- RESTORE institute, University of Toulouse, CNRS, Toulouse, France
| | - Céline Berrone
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
- Level 3 Biosafety Animal Core facility, Anexplo platform, Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Nino Iakobachvili
- Division of Nanoscopy, Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, The Netherlands
| | - Arnaud Metais
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Yoann Rombouts
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Geanncarlo Lugo-Villarino
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Agnès Coste
- RESTORE institute, University of Toulouse, CNRS, Toulouse, France
| | - Ina Attrée
- Univ. Grenoble Alpes, CNRS, CEA, IBS, Bacterial Pathogenesis and Cellular Responses, Grenoble, France
| | - Dara W. Frank
- Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America
| | - Hans Clevers
- Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, Netherlands
| | - Peter J. Peters
- Division of Nanoscopy, Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, The Netherlands
| | - Céline Cougoule
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Rémi Planès
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| | - Etienne Meunier
- Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France
| |
Collapse
|
6
|
Trimaglio G, Tilkin-Mariamé AF, Feliu V, Lauzéral-Vizcaino F, Tosolini M, Valle C, Ayyoub M, Neyrolles O, Vergnolle N, Rombouts Y, Devaud C. Colon-specific immune microenvironment regulates cancer progression versus rejection. Oncoimmunology 2020; 9:1790125. [PMID: 32923152 PMCID: PMC7458593 DOI: 10.1080/2162402x.2020.1790125] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Immunotherapies have achieved clinical benefit in many types of cancer but remain limited to a subset of patients in colorectal cancer (CRC). Resistance to immunotherapy can be attributed in part to tissue-specific factors constraining antitumor immunity. Thus, a better understanding of how the colon microenvironment shapes the immune response to CRC is needed to identify mechanisms of resistance to immunotherapies and guide the development of novel therapeutics. In an orthotopic mouse model of MC38-CRC, tumor progression was monitored by bioluminescence imaging and the immune signatures were assessed at a transcriptional level using NanoString and at a cellular level by flow cytometry. Despite initial tumor growth in all mice, only 25% to 35% of mice developed a progressive lethal CRC while the remaining animals spontaneously rejected their solid tumor. No tumor rejection was observed in the absence of adaptive immunity, nor when MC38 cells were injected in non-orthotopic locations, subcutaneously or into the liver. We observed that progressive CRC tumors exhibited a protumor immune response, characterized by a regulatory T-lymphocyte pattern, discernible shortly post-tumor implantation, as well as suppressive myeloid cells. In contrast, tumor-rejecting mice presented an early inflammatory response and an antitumor microenvironment enriched in CD8+ T cells. Taken together, our data demonstrate the role of the colon microenvironment in regulating the balance between anti or protumor immune responses. While emphasizing the relevance of the CRC orthotopic model, they set the basis for exploring the impact of the identified signatures in colon cancer response to immunotherapy.
Collapse
Affiliation(s)
- Giulia Trimaglio
- Institut De Pharmacologie Et De Biologie Structurale (IPBS), Université De Toulouse, CNRS, UPS, Toulouse, France
| | | | - Virginie Feliu
- Centre De Recherches En Cancérologie De Toulouse (CRCT), INSERM U1037, Toulouse, France.,Immune Monitoring Core Facility, Institut Universitaire Du Cancer (IUCT)- Oncopôle, Toulouse, France
| | - Françoise Lauzéral-Vizcaino
- Immune Monitoring Core Facility, Institut Universitaire Du Cancer (IUCT)- Oncopôle, Toulouse, France.,Université Toulouse III Paul Sabatier, Toulouse, France
| | - Marie Tosolini
- Centre De Recherches En Cancérologie De Toulouse (CRCT), INSERM U1037, Toulouse, France
| | - Carine Valle
- Centre De Recherches En Cancérologie De Toulouse (CRCT), INSERM U1037, Toulouse, France
| | - Maha Ayyoub
- Centre De Recherches En Cancérologie De Toulouse (CRCT), INSERM U1037, Toulouse, France.,Immune Monitoring Core Facility, Institut Universitaire Du Cancer (IUCT)- Oncopôle, Toulouse, France.,Université Toulouse III Paul Sabatier, Toulouse, France
| | - Olivier Neyrolles
- Institut De Pharmacologie Et De Biologie Structurale (IPBS), Université De Toulouse, CNRS, UPS, Toulouse, France
| | - Nathalie Vergnolle
- INSERM (U1220), INRA, ENVT, UPS, Institut De Recherche En Santé Digestive (IRSD), Toulouse, France
| | - Yoann Rombouts
- Institut De Pharmacologie Et De Biologie Structurale (IPBS), Université De Toulouse, CNRS, UPS, Toulouse, France
| | - Christel Devaud
- INSERM (U1220), INRA, ENVT, UPS, Institut De Recherche En Santé Digestive (IRSD), Toulouse, France
| |
Collapse
|
7
|
Dupont M, Souriant S, Balboa L, Vu Manh TP, Pingris K, Rousset S, Cougoule C, Rombouts Y, Poincloux R, Ben Neji M, Allers C, Kaushal D, Kuroda MJ, Benet S, Martinez-Picado J, Izquierdo-Useros N, Sasiain MDC, Maridonneau-Parini I, Neyrolles O, Vérollet C, Lugo-Villarino G. Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages. eLife 2020; 9:52535. [PMID: 32223897 PMCID: PMC7173963 DOI: 10.7554/elife.52535] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2019] [Accepted: 03/30/2020] [Indexed: 12/20/2022] Open
Abstract
While tuberculosis (TB) is a risk factor in HIV-1-infected individuals, the mechanisms by which Mycobacterium tuberculosis (Mtb) worsens HIV-1 pathogenesis remain scarce. We showed that HIV-1 infection is exacerbated in macrophages exposed to TB-associated microenvironments due to tunneling nanotube (TNT) formation. To identify molecular factors associated with TNT function, we performed a transcriptomic analysis in these macrophages, and revealed the up-regulation of Siglec-1 receptor. Siglec-1 expression depends on Mtb-induced production of type I interferon (IFN-I). In co-infected non-human primates, Siglec-1 is highly expressed by alveolar macrophages, whose abundance correlates with pathology and activation of IFN-I/STAT1 pathway. Siglec-1 localizes mainly on microtubule-containing TNT that are long and carry HIV-1 cargo. Siglec-1 depletion decreases TNT length, diminishes HIV-1 capture and cell-to-cell transfer, and abrogates the exacerbation of HIV-1 infection induced by Mtb. Altogether, we uncover a deleterious role for Siglec-1 in TB-HIV-1 co-infection and open new avenues to understand TNT biology.
Collapse
Affiliation(s)
- Maeva Dupont
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.,International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France
| | - Shanti Souriant
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.,International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France
| | - Luciana Balboa
- International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France.,Institute of Experimental Medicine-CONICET, National Academy of Medicine, Buenos Aires, Argentina
| | | | - Karine Pingris
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Stella Rousset
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Céline Cougoule
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.,International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France
| | - Yoann Rombouts
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Renaud Poincloux
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Myriam Ben Neji
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Carolina Allers
- Tulane National Primate Research Center, Department of Microbiology and Immunology, School of Medicine, Tulane University, Covington, United States
| | - Deepak Kaushal
- Tulane National Primate Research Center, Department of Microbiology and Immunology, School of Medicine, Tulane University, Covington, United States
| | - Marcelo J Kuroda
- Tulane National Primate Research Center, Department of Microbiology and Immunology, School of Medicine, Tulane University, Covington, United States
| | - Susana Benet
- IrsiCaixa AIDS Research Institute, Department of Retrovirology, Badalona, Spain.,Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Javier Martinez-Picado
- IrsiCaixa AIDS Research Institute, Department of Retrovirology, Badalona, Spain.,University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.,Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
| | - Nuria Izquierdo-Useros
- IrsiCaixa AIDS Research Institute, Department of Retrovirology, Badalona, Spain.,Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
| | - Maria Del Carmen Sasiain
- International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France.,Institute of Experimental Medicine-CONICET, National Academy of Medicine, Buenos Aires, Argentina
| | - Isabelle Maridonneau-Parini
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.,International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France
| | - Olivier Neyrolles
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.,International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France
| | - Christel Vérollet
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.,International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France
| | - Geanncarlo Lugo-Villarino
- Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.,International associated laboratory (LIA) CNRS 'IM-TB/HIV', Toulouse, France
| |
Collapse
|
8
|
Pirro M, Rombouts Y, Stella A, Neyrolles O, Burlet-Schiltz O, van Vliet SJ, de Ru AH, Mohammed Y, Wuhrer M, van Veelen PA, Hensbergen PJ. Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines. Biochim Biophys Acta Gen Subj 2020; 1864:129513. [PMID: 31911241 DOI: 10.1016/j.bbagen.2020.129513] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2019] [Revised: 12/20/2019] [Accepted: 01/02/2020] [Indexed: 12/14/2022]
Abstract
BACKGROUND The Ca2+-dependent C-type lectin receptor Macrophage Galactose-type Lectin (MGL) is highly expressed by tolerogenic dendritic cells (DC) and macrophages. MGL exhibits a high binding specificity for terminal alpha- and beta-linked GalNAc residues found in Tn, sTn and LacdiNAc antigens. These glycan epitopes are often overexpressed in colorectal cancer (CRC), and, as such, MGL can be used to discriminate tumor from the corresponding healthy tissues. Moreover, the high expression of MGL ligands is associated with poor disease-free survival in stage III of CRC tumors. Nonetheless, the glycoproteins expressed by tumor cells that are recognized by MGL have hitherto remained elusive. METHODS Using a panel of three CRC cell lines (HCT116, HT29 and LS174T), recapitulating CRC diversity, we performed FACS staining and pull-down assays using a recombinant soluble form of MGL (and a mutant MGL as control) combined with mass spectrometry-based (glyco)proteomics. RESULTS HCT116 and HT29, but not LS174T, are high MGL-binding CRC cell lines. On these cells, the major cell surface binding proteins are receptors (e.g. MET, PTK7, SORL1, PTPRF) and integrins (ITGB1, ITGA3). From these proteins, several N- and/or O-glycopeptides were identified, of which some carried either a LacdiNAc or Tn epitope. CONCLUSIONS We have identified cell surface MGL-ligands on CRC cell lines. GENERAL SIGNIFICANCE Advances in (glyco)proteomics have led to identification of candidate key mediators of immune-evasion and tumor growth in CRC.
Collapse
Affiliation(s)
- Martina Pirro
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Yoann Rombouts
- Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Alexandre Stella
- Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Olivier Neyrolles
- Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Odile Burlet-Schiltz
- Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Sandra J van Vliet
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands
| | - Arnoud H de Ru
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Yassene Mohammed
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Peter A van Veelen
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Paul J Hensbergen
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
| |
Collapse
|
9
|
Grötsch B, Lux A, Rombouts Y, Hoffmann AC, Andreev D, Nimmerjahn F, Xiang W, Scherer HU, Schett G, Bozec A. Fra1 Controls Rheumatoid Factor Autoantibody Production by Bone Marrow Plasma Cells and the Development of Autoimmune Bone Loss. J Bone Miner Res 2019; 34:1352-1365. [PMID: 30779858 DOI: 10.1002/jbmr.3705] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2018] [Revised: 01/21/2019] [Accepted: 02/05/2019] [Indexed: 11/11/2022]
Abstract
Next to proinflammatory cytokines, autoimmunity has been identified as a key trigger for osteoclast activation and bone loss. IgG-rheumatoid factor (IgG-RF) immune complexes, which are present in patients with rheumatoid arthritis, were shown to boost osteoclast differentiation. To date, the regulation of IgG-RF production in the absence of inflammatory triggers is unknown. Herein, we describe Fra1 as a key checkpoint that controls IgG-RF production by plasma cells and regulates autoimmune-mediated bone loss. Fra1 deficiency in B cells (Fra1ΔBcell ) led to increased IgG1-producing bone marrow plasma cells, enhanced IgG-RF production, and increased bone loss associated with elevated osteoclast numbers after immunization. The effect of IgG-RF on osteoclasts in vitro and on osteoclasts associated with bone loss in vivo was dependent on FcγR, especially FcγR3. Furthermore, immunization of WT mice with T-cell-dependent antigens induced a significant and robust decrease in Fra1 expression in bone marrow B cells, which was followed by increased IgG1 production and the induction of osteoclast-mediated bone loss. Overall, these data identify Fra1 as a key mediator of IgG-RF production and autoimmune-mediated bone loss. © 2019 American Society for Bone and Mineral Research.
Collapse
Affiliation(s)
- Bettina Grötsch
- Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Anja Lux
- Division of Genetics, University of Erlangen-Nuremberg, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Yoann Rombouts
- Leiden University Medical Center, Leiden, The Netherlands.,Institut de Pharmacologie et de Biologie Structurale, CNRS/University of Toulouse, France
| | - Anna-Carin Hoffmann
- Institute of Biochemistry, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Darja Andreev
- Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Falk Nimmerjahn
- Division of Genetics, University of Erlangen-Nuremberg, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Wei Xiang
- Institute of Biochemistry, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| | | | - Georg Schett
- Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Aline Bozec
- Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
| |
Collapse
|
10
|
Lugo-Villarino G, Cougoule C, Meunier E, Rombouts Y, Vérollet C, Balboa L. Editorial: The Mononuclear Phagocyte System in Infectious Disease. Front Immunol 2019; 10:1443. [PMID: 31293593 PMCID: PMC6606713 DOI: 10.3389/fimmu.2019.01443] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Accepted: 06/10/2019] [Indexed: 12/23/2022] Open
Affiliation(s)
- Geanncarlo Lugo-Villarino
- CNRS, UPS, Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, Toulouse, France.,International Associated Laboratory, CNRS "IM-TB/HIV" (1167), Toulouse, France
| | - Céline Cougoule
- CNRS, UPS, Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, Toulouse, France.,International Associated Laboratory, CNRS "IM-TB/HIV" (1167), Toulouse, France
| | - Etienne Meunier
- CNRS, UPS, Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, Toulouse, France
| | - Yoann Rombouts
- CNRS, UPS, Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, Toulouse, France
| | - Christel Vérollet
- CNRS, UPS, Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, Toulouse, France.,International Associated Laboratory, CNRS "IM-TB/HIV" (1167), Toulouse, France
| | - Luciana Balboa
- International Associated Laboratory, CNRS "IM-TB/HIV" (1167), Toulouse, France.,IMEX-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina
| |
Collapse
|
11
|
Holst S, Wilding JL, Koprowska K, Rombouts Y, Wuhrer M. N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines. Cells 2019; 8:cells8030273. [PMID: 30909444 PMCID: PMC6468459 DOI: 10.3390/cells8030273] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2019] [Revised: 03/13/2019] [Accepted: 03/18/2019] [Indexed: 12/13/2022] Open
Abstract
The caudal-related homeobox protein 1 (CDX1) is a transcription factor, which is important in the development, differentiation, and homeostasis of the gut. Although the involvement of CDX genes in the regulation of the expression levels of a few glycosyltransferases has been shown, associations between glycosylation phenotypes and CDX1 mRNA expression have hitherto not been well studied. Triggered by our previous study, we here characterized the N-glycomic phenotype of 16 colon cancer cell lines, selected for their differential CDX1 mRNA expression levels. We found that high CDX1 mRNA expression associated with a higher degree of multi-fucosylation on N-glycans, which is in line with our previous results and was supported by up-regulated gene expression of fucosyltransferases involved in antenna fucosylation. Interestingly, hepatocyte nuclear factors (HNF)4A and HNF1A were, among others, positively associated with high CDX1 mRNA expression and have been previously proven to regulate antenna fucosylation. Besides fucosylation, we found that high CDX1 mRNA expression in cancer cell lines also associated with low levels of sialylation and galactosylation and high levels of bisection on N-glycans. Altogether, our data highlight a possible role of CDX1 in altering the N-glycosylation of colorectal cancer cells, which is a hallmark of tumor development.
Collapse
Affiliation(s)
- Stephanie Holst
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
| | - Jennifer L Wilding
- Cancer and Immunogenetics Laboratory, Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, UK.
| | - Kamila Koprowska
- Cancer and Immunogenetics Laboratory, Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, UK.
| | - Yoann Rombouts
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
- Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
| |
Collapse
|
12
|
Pirro M, Schoof E, van Vliet SJ, Rombouts Y, Stella A, de Ru A, Mohammed Y, Wuhrer M, van Veelen PA, Hensbergen PJ. Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells. J Proteome Res 2019; 18:1125-1132. [PMID: 30582698 PMCID: PMC6399673 DOI: 10.1021/acs.jproteome.8b00796] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
![]()
C-type lectins are
a diverse group of proteins involved in many
human physiological and pathological processes. Most C-type lectins
are glycan-binding proteins, some of which are pivotal for innate
immune responses against pathogens. Other C-type lectins, such as
the macrophage galactose-type lectin (MGL), have been shown to induce
immunosuppressive responses upon the recognition of aberrant glycosylation
on cancer cells. MGL is known to recognize terminal N-acetylgalactosamine (GalNAc), such as the Tn antigen, which is commonly
found on malignant cells. Even though this glycan specificity of MGL
is well described, there is a lack of understanding of the actual
glycoproteins that bind MGL. We present a glycoproteomic workflow
for the identification of MGL-binding proteins, which we applied to
study MGL ligands on the human Jurkat leukemia cell line. In addition
to the known MGL ligands and Tn antigen-carrying proteins CD43 and
CD45 on these cells, we have identified a set of novel cell-surface
ligands for MGL. Importantly, for several of these, O-glycosylation
has hitherto not been described. Altogether, our data provide new
insight into the identification and structure of novel MGL ligands
that presumably act as modulatory molecules in cancer immune responses.
Collapse
Affiliation(s)
- Martina Pirro
- Center for Proteomics and Metabolomics , Leiden University Medical Center , 2300 RC Leiden , The Netherlands
| | - Esmee Schoof
- Center for Proteomics and Metabolomics , Leiden University Medical Center , 2300 RC Leiden , The Netherlands
| | - Sandra J van Vliet
- Amsterdam UMC, Vrije Universiteit Amsterdam, Dept. of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, 1007 MB Amsterdam , The Netherlands
| | - Yoann Rombouts
- Institut de Pharmacologie et de Biologie Structurale , Université de Toulouse, CNRS, UPS , Toulouse 31062 , France
| | - Alexandre Stella
- Institut de Pharmacologie et de Biologie Structurale , Université de Toulouse, CNRS, UPS , Toulouse 31062 , France
| | - Arnoud de Ru
- Center for Proteomics and Metabolomics , Leiden University Medical Center , 2300 RC Leiden , The Netherlands
| | - Yassene Mohammed
- Center for Proteomics and Metabolomics , Leiden University Medical Center , 2300 RC Leiden , The Netherlands
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics , Leiden University Medical Center , 2300 RC Leiden , The Netherlands
| | - Peter A van Veelen
- Center for Proteomics and Metabolomics , Leiden University Medical Center , 2300 RC Leiden , The Netherlands
| | - Paul J Hensbergen
- Center for Proteomics and Metabolomics , Leiden University Medical Center , 2300 RC Leiden , The Netherlands
| |
Collapse
|
13
|
Bondt A, Hafkenscheid L, Falck D, Kuijper TM, Rombouts Y, Hazes JMW, Wuhrer M, Dolhain RJEM. ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis. Ann Rheum Dis 2018; 77:1130-1136. [PMID: 29615411 DOI: 10.1136/annrheumdis-2018-212946] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2018] [Revised: 03/16/2018] [Accepted: 03/22/2018] [Indexed: 11/04/2022]
Abstract
OBJECTIVES Patients with autoantibody-positive rheumatoid arthritis (RA) are less likely to experience pregnancy-induced improvement of RA disease activity (DAS28-C reactive protein (CRP)) compared with patients with autoantibody-negative RA. Anti-citrullinated protein antibodies (ACPAs) are the most specific autoantibodies for RA. We previously demonstrated that disease improvement is associated with changes in total IgG glycosylation, which regulate antibody effector function. Therefore, we sought to analyse the ACPA-IgG glycosylation profile during pregnancy with the aim to understand the lower change of pregnancy-induced improvement of the disease in patients with autoantibody-positive RA. METHODS ACPA-IgGs were purified from ACPA-positive patient sera (n=112) of the Pregnancy-induced Amelioration of Rheumatoid Arthritis cohort, a prospective study designed to investigate pregnancy-associated improvement of RA. The fragment crystallisable (Fc)glycosylation profile of ACPA-IgGs was characterised by mass spectrometry and compared with that of total IgG derived from the same patients or from ACPA-negative patients. RESULTS All ACPA-IgG subclasses display significant changes in the level of galactosylation and sialylation during pregnancy, although less pronounced than in total IgG. The pregnancy-induced increase in ACPA-IgG galactosylation, but not sialylation, associates with lower DAS28-CRP. In ACPA-positive patients, no such association was found with changes in the galactosylation of total IgG, whereas in ACPA-negative patients changes in disease activity correlated well with changes in the galactosylation of total IgG. CONCLUSIONS In ACPA-positive RA, the pregnancy-induced change in galactosylation of ACPA-IgG, and not that of total IgG, associates with changes in disease activity. These data may indicate that in ACPA-positive patients the galactosylation of ACPA-IgG is of more pathogenic relevance than that of total IgG.
Collapse
Affiliation(s)
- Albert Bondt
- Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands.,Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.,Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
| | - Lise Hafkenscheid
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
| | - David Falck
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands
| | - T Martijn Kuijper
- Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Yoann Rombouts
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.,Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.,Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, Toulouse, France
| | - Johanna M W Hazes
- Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands
| | - Radboud J E M Dolhain
- Department of Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands
| |
Collapse
|
14
|
Kempers AC, Nejadnik MR, Rombouts Y, Ioan-Facsinay A, van Oosterhout M, Jiskoot W, Huizinga TWJ, Toes REM, Scherer HU. Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for FcγRI in the pathogenesis of synovial inflammation. Clin Exp Rheumatol 2018; 36:284-293. [PMID: 29352854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2017] [Accepted: 08/01/2017] [Indexed: 06/07/2023]
Abstract
OBJECTIVES Anti-citrullinated protein antibodies (ACPA) are highly specific for rheumatoid arthritis (RA). Here, we studied binding of ACPA-IgG immune complexes (IC) to individual Fc gamma receptors (FcγR) to identify potential effector mechanisms by which ACPA could contribute to RA pathogenesis. METHODS ACPA-IgG1 and control IgG1(IgG1 depleted of ACPA-IgG1) were isolated from plasma and synovial fluid (SF) of RA patients by affinity chromatography using CCP2 peptides. Subsequently, IC were generated using fluorescently labelled F(ab')2 fragments against the F(ab')2 region of IgG, or by using citrullinated fibrinogen. IC were incubated with FcγR-transfected CHO cell lines or neutrophils from healthy donors. FcγR binding of IC was analysed by flow cytometry in the presence or absence of specific blocking antibodies. RESULTS ACPA-IgG1 IC predominantly bound to FcγRI and FcγRIIIA on FcγR-transfected CHO cell lines, while much lower binding was observed to FcγRIIA and FcγRIIB. ACPA-IgG1 IC showed reduced binding to FcγRIIIA compared to control IgG1 IC, in line with enhanced ACPA-IgG1 Fc core-fucosylation. Neutrophils activated in vitro to induce de novo expression of FcγRI showed binding of ACPA-IgG IC, and blocking studies revealed that almost 30% of ACPA-IgG IC binding to activated neutrophils was mediated by FcγRI. CONCLUSIONS Our studies show that ACPA-IgG1 IC bind predominately to activating FcγRI and FcγRIIIA, and highlight FcγRI expressed by activated neutrophils as relevant receptor for these IC. As neutrophils isolated from SF exhibit an activated state and express FcγRI in the synovial compartment, this IC-binding could contribute to driving disease pathogenesis in RA.
Collapse
Affiliation(s)
- Ayla C Kempers
- Department of Rheumatology, Leiden University Medical Center, The Netherlands
| | - M Reza Nejadnik
- Division of Drug Delivery Technology, Cluster BioTherapeutics, Leiden Academic Center for Drug Research, Leiden University, The Netherlands
| | - Yoann Rombouts
- Department of Rheumatology, Leiden University Medical Center; Center for Proteomics and Metabolomics, Leiden University Medical Center; and Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, France
| | | | | | - Wim Jiskoot
- Division of Drug Delivery Technology, Cluster BioTherapeutics, Leiden Academic Center for Drug Research, Leiden University, The Netherlands
| | - Tom W J Huizinga
- Department of Rheumatology, Leiden University Medical Center, The Netherlands
| | - René E M Toes
- Department of Rheumatology, Leiden University Medical Center, The Netherlands
| | - Hans Ulrich Scherer
- Department of Rheumatology, Leiden University Medical Center, The Netherlands.
| |
Collapse
|
15
|
Holst S, van Pelt GW, Mesker WE, Tollenaar RA, Belo AI, van Die I, Rombouts Y, Wuhrer M. High-Throughput and High-Sensitivity Mass Spectrometry-Based N-Glycomics of Mammalian Cells. Methods Mol Biol 2017; 1503:185-196. [PMID: 27743367 DOI: 10.1007/978-1-4939-6493-2_14] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
The current protocols for glycomic analysis of cells often require a large quantity of material (5-20 million cells). In order to analyze the N-glycosylation from small amounts of cells (≤1 million) as obtained from, for example, primary cell lines or cell sorting, and in a higher throughput approach, we set up a robust 96-well format PVDF-membrane based N-glycan release protocol followed by linkage-specific sialic acid stabilization, cleanup, and MALDI-TOF-MS analysis. We further evaluated the influence of PNGase F incubation time on the N-glycan profile.
Collapse
Affiliation(s)
- Stephanie Holst
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Postzone S3, Postbus 9600, 2300, RC, Leiden, The Netherlands.
| | - Gabi W van Pelt
- Department of Surgery, Leiden University Medical Center, Postbus 9600, RC, 2300, Leiden, The Netherlands
| | - Wilma E Mesker
- Department of Surgery, Leiden University Medical Center, Postbus 9600, RC, 2300, Leiden, The Netherlands
| | - Rob A Tollenaar
- Department of Surgery, Leiden University Medical Center, Postbus 9600, RC, 2300, Leiden, The Netherlands
| | - Ana I Belo
- Department of Molecular Cell Biology and Immunology, VU University Medical Centre, Amsterdam, The Netherlands
| | - Irma van Die
- Department of Molecular Cell Biology and Immunology, VU University Medical Centre, Amsterdam, The Netherlands
| | - Yoann Rombouts
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Postzone S3, Postbus 9600, 2300, RC, Leiden, The Netherlands
- University Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59 000, Lille, France
| | - Manfred Wuhrer
- Division of BioAnalytical Chemistry, VU University Amsterdam, De Boelelaan 1083, Amsterdam, 1081, HV, The Netherlands
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333, ZA, The Netherlands
| |
Collapse
|
16
|
Pfeifle R, Rothe T, Ipseiz N, Scherer HU, Culemann S, Harre U, Ackermann JA, Seefried M, Kleyer A, Uderhardt S, Haugg B, Hueber AJ, Daum P, Heidkamp GF, Ge C, Böhm S, Lux A, Schuh W, Magorivska I, Nandakumar KS, Lönnblom E, Becker C, Dudziak D, Wuhrer M, Rombouts Y, Koeleman CA, Toes R, Winkler TH, Holmdahl R, Herrmann M, Blüml S, Nimmerjahn F, Schett G, Krönke G. Regulation of autoantibody activity by the IL-23-T H17 axis determines the onset of autoimmune disease. Nat Immunol 2017; 18:104-113. [PMID: 27820809 PMCID: PMC5164937 DOI: 10.1038/ni.3579] [Citation(s) in RCA: 229] [Impact Index Per Article: 32.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Accepted: 09/08/2016] [Indexed: 12/12/2022]
Abstract
The checkpoints and mechanisms that contribute to autoantibody-driven disease are as yet incompletely understood. Here we identified the axis of interleukin 23 (IL-23) and the TH17 subset of helper T cells as a decisive factor that controlled the intrinsic inflammatory activity of autoantibodies and triggered the clinical onset of autoimmune arthritis. By instructing B cells in an IL-22- and IL-21-dependent manner, TH17 cells regulated the expression of β-galactoside α2,6-sialyltransferase 1 in newly differentiating antibody-producing cells and determined the glycosylation profile and activity of immunoglobulin G (IgG) produced by the plasma cells that subsequently emerged. Asymptomatic humans with rheumatoid arthritis (RA)-specific autoantibodies showed identical changes in the activity and glycosylation of autoreactive IgG antibodies before shifting to the inflammatory phase of RA; thus, our results identify an IL-23-TH17 cell-dependent pathway that controls autoantibody activity and unmasks a preexisting breach in immunotolerance.
Collapse
Affiliation(s)
- René Pfeifle
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Tobias Rothe
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Natacha Ipseiz
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Hans U Scherer
- Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands
| | - Stephan Culemann
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Ulrike Harre
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
| | - Jochen A Ackermann
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Martina Seefried
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
- Institute of Genetics at the Department of Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Arnd Kleyer
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
| | - Stefan Uderhardt
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Benjamin Haugg
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Axel J Hueber
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
| | - Patrick Daum
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
- Division of Molecular Immunology, Department of Internal Medicine 3, University Hospital Erlangen, Erlangen, Germany
| | - Gordon F Heidkamp
- Department of Dermatology, Laboratory of Dendritic Cell Biology, University Hospital Erlangen, Erlangen, Germany
| | - Changrong Ge
- Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Sybille Böhm
- Institute of Genetics at the Department of Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Anja Lux
- Institute of Genetics at the Department of Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Wolfgang Schuh
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
- Division of Molecular Immunology, Department of Internal Medicine 3, University Hospital Erlangen, Erlangen, Germany
| | - Iryna Magorivska
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
| | - Kutty S Nandakumar
- Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Erik Lönnblom
- Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Christoph Becker
- Department of Medicine 1, University Hospital Erlangen, Erlangen, Germany
| | - Diana Dudziak
- Department of Dermatology, Laboratory of Dendritic Cell Biology, University Hospital Erlangen, Erlangen, Germany
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Yoann Rombouts
- Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
- Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, France
| | - Carolien A Koeleman
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - René Toes
- Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands
| | - Thomas H Winkler
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
- Institute of Genetics at the Department of Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Rikard Holmdahl
- Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Martin Herrmann
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
| | - Stephan Blüml
- Division of Rheumatology, Internal Medicine 3, Medical University Vienna, Vienna, Austria
| | - Falk Nimmerjahn
- Institute of Genetics at the Department of Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Georg Schett
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
| | - Gerhard Krönke
- Department of Internal Medicine 3 and Institute for Clinical Immunology, University Hospital Erlangen, Erlangen, Germany
- Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| |
Collapse
|
17
|
Hafkenscheid L, Bondt A, Scherer HU, Huizinga TWJ, Wuhrer M, Toes REM, Rombouts Y. Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans. Mol Cell Proteomics 2016; 16:278-287. [PMID: 27956708 DOI: 10.1074/mcp.m116.062919] [Citation(s) in RCA: 77] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Revised: 11/16/2016] [Indexed: 11/06/2022] Open
Abstract
Recently, we showed the unexpectedly high abundance of N-linked glycans on the Fab-domain of Anti-Citrullinated Protein Antibodies (ACPA). As N-linked glycans can mediate a variety of biological functions, we now aimed at investigating the structural composition of the Fab-glycans of ACPA-IgG to better understand their mediated biological effects. ACPA-IgG and noncitrulline specific (control) IgG from plasma and/or synovial fluid of nine ACPA positive rheumatoid arthritis patients were affinity purified. The N-linked glycosylation of total, Fc and F(ab')2 fragments, as well as heavy and light chains of ACPA-IgG and control IgG were analyzed by UHPLC and MALDI-TOF mass spectrometry. The Fc-glycosylation of ACPA-IgG and IgG was analyzed at the glycopeptide level using LC-MS. The structural analyses revealed that ACPA-IgG molecules contain highly sialylated glycans in their Fab-domain. Importantly, Fab-glycans were estimated to be present on over 90% of ACPA-IgG, which is five times higher than in control IgG isolated from the same patients. This feature was more prominent on ACPA isolated from synovial fluid compared with peripheral blood. These observations provide the first evidence pointing to the ability of ACPA-IgG to mediate novel immunological activities, for example through binding specific lectins via hyper-sialylated Fab-glycans.
Collapse
Affiliation(s)
- Lise Hafkenscheid
- From the ‡Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands;
| | - Albert Bondt
- From the ‡Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands.,§Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, the Netherlands
| | - Hans U Scherer
- From the ‡Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands
| | - Tom W J Huizinga
- From the ‡Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands
| | - Manfred Wuhrer
- §Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, the Netherlands
| | - René E M Toes
- From the ‡Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands
| | - Yoann Rombouts
- From the ‡Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands.,§Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, the Netherlands.,¶Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, France
| |
Collapse
|
18
|
Abstract
Glycosylation is an abundant and important protein modification with large influence on the properties and interactions of glycoconjugates. Human plasma N-glycosylation has been the subject of frequent investigation, revealing strong associations with physiological and pathological conditions. Less well-characterized is the plasma N-glycosylation of the mouse, the most commonly used animal model for studying human diseases, particularly with regard to differences between strains and sexes. For this reason, we used MALDI-TOF(/TOF)-MS(/MS) assisted by linkage-specific derivatization of the sialic acids to comparatively analyze the plasma N-glycosylation of both male and female mice originating from BALB/c, CD57BL/6, CD-1, and Swiss Webster strains. The combined use of this analytical method and the recently developed data processing software named MassyTools allowed the relative quantification of the N-glycan species within plasma, the distinction between α2,3- and α2,6-linked N-glycolylneuraminic acids (due to respective lactonization and ethyl esterification), the detection of sialic acid O-acetylation, as well as the characterization of branching sialylation (Neu5Gcα2,3-Hex-[Neu5Gcα2,6-]HexNAc). When analyzing the glycosylation according to mouse sex, we found that female mice present a considerably higher degree of core fucosylation (2-4-fold depending on the strain), galactosylation, α2,6-linked sialylation, and larger high-mannose type glycan species compared with their male counterparts. Male mice, on the contrary, showed on average higher α2,3-linked sialylation, branching sialylation, and putative bisection. These differences together with sialic acid acetylation proved to be strain-specific as well. Interestingly, the outbred strains CD-1 and Swiss Webster displayed considerably larger interindividual variation than inbred strains BALB/c and CD57BL/6, suggesting a strong hereditable component of the observed plasma N-glycome.
Collapse
Affiliation(s)
- Karli R Reiding
- Leiden University Medical Center , Center for Proteomics and Metabolomics, Leiden 2333ZA, The Netherlands
| | - Agnes L Hipgrave Ederveen
- Leiden University Medical Center , Center for Proteomics and Metabolomics, Leiden 2333ZA, The Netherlands
| | - Yoann Rombouts
- Leiden University Medical Center , Center for Proteomics and Metabolomics, Leiden 2333ZA, The Netherlands.,Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France
| | - Manfred Wuhrer
- Leiden University Medical Center , Center for Proteomics and Metabolomics, Leiden 2333ZA, The Netherlands
| |
Collapse
|
19
|
Delannoy CP, Rombouts Y, Groux-Degroote S, Holst S, Coddeville B, Harduin-Lepers A, Wuhrer M, Elass-Rochard E, Guérardel Y. Glycosylation Changes Triggered by the Differentiation of Monocytic THP-1 Cell Line into Macrophages. J Proteome Res 2016; 16:156-169. [DOI: 10.1021/acs.jproteome.6b00161] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Clément P. Delannoy
- Univ. Lille, CNRS, UMR 8576 - UGSF - Unité
de Glycobiologie Structurale et Fonctionnelle, F 59000 Lille, France
| | - Yoann Rombouts
- Univ. Lille, CNRS, UMR 8576 - UGSF - Unité
de Glycobiologie Structurale et Fonctionnelle, F 59000 Lille, France
| | - Sophie Groux-Degroote
- Univ. Lille, CNRS, UMR 8576 - UGSF - Unité
de Glycobiologie Structurale et Fonctionnelle, F 59000 Lille, France
| | - Stephanie Holst
- Center
for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Bernadette Coddeville
- Univ. Lille, CNRS, UMR 8576 - UGSF - Unité
de Glycobiologie Structurale et Fonctionnelle, F 59000 Lille, France
| | - Anne Harduin-Lepers
- Univ. Lille, CNRS, UMR 8576 - UGSF - Unité
de Glycobiologie Structurale et Fonctionnelle, F 59000 Lille, France
| | - Manfred Wuhrer
- Center
for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Elisabeth Elass-Rochard
- Univ. Lille, CNRS, UMR 8576 - UGSF - Unité
de Glycobiologie Structurale et Fonctionnelle, F 59000 Lille, France
| | - Yann Guérardel
- Univ. Lille, CNRS, UMR 8576 - UGSF - Unité
de Glycobiologie Structurale et Fonctionnelle, F 59000 Lille, France
| |
Collapse
|
20
|
Abstract
Human IgG is the most abundant glycoprotein in serum and is crucial for protective immunity. In addition to conserved IgG Fc glycans, ∼15-25% of serum IgG contains glycans within the variable domains. These so-called "Fab glycans" are primarily highly processed complex-type biantennary N-glycans linked to N-glycosylation sites that emerge during somatic hypermutation. Specific patterns of Fab glycosylation are concurrent with physiological and pathological conditions, such as pregnancy and rheumatoid arthritis. With respect to function, Fab glycosylation can significantly affect stability, half-life, and binding characteristics of Abs and BCRs. Moreover, Fab glycans are associated with the anti-inflammatory activity of IVIgs. Consequently, IgG Fab glycosylation appears to be an important, yet poorly understood, process that modulates immunity.
Collapse
Affiliation(s)
- Fleur S van de Bovenkamp
- Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands
| | - Lise Hafkenscheid
- Department of Rheumatology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands
| | - Theo Rispens
- Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands;
| | - Yoann Rombouts
- Department of Rheumatology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands; Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands; and Université Lille, CNRS, UMR 8576, Unité de Glycobiologie Structurale et Fonctionnelle, F 59 000 Lille, France
| |
Collapse
|
21
|
Jansen BC, Bondt A, Reiding KR, Lonardi E, de Jong CJ, Falck D, Kammeijer GSM, Dolhain RJEM, Rombouts Y, Wuhrer M. Pregnancy-associated serum N-glycome changes studied by high-throughput MALDI-TOF-MS. Sci Rep 2016; 6:23296. [PMID: 27075729 PMCID: PMC4831011 DOI: 10.1038/srep23296] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2015] [Accepted: 02/15/2016] [Indexed: 01/30/2023] Open
Abstract
Pregnancy requires partial suppression of the immune system to ensure maternal-foetal tolerance. Protein glycosylation, and especially terminal sialic acid linkages, are of prime importance in regulating the pro- and anti-inflammatory immune responses. However, little is known about pregnancy-associated changes of the serum N-glycome and sialic acid linkages. Using a combination of recently developed methods, i.e. derivatisation that allows the distinction between α2,3- and α2,6-linked sialic acids by high-throughput MALDI-TOF-MS and software-assisted data processing, we analysed the serum N-glycome of a cohort of 29 healthy women at 6 time points during and after pregnancy. A total of 77 N-glycans were followed over time, confirming in part previous findings while also revealing novel associations (e.g. an increase of FA2BG1S1(6), FA2G1S1(6) and A2BG2S2(6) with delivery). From the individual glycans we calculated 42 derived traits. With these, an increase during pregnancy and decrease after delivery was observed for both α2,3- and α2,6-linked sialylation. Additionally, a difference in the recovery speed after delivery was observed for α2,3- and α2,6-linked sialylation of triantennary glycans. In conclusion, our new high-throughput workflow allowed the identification of novel plasma glycosylation changes with pregnancy.
Collapse
Affiliation(s)
- Bas C Jansen
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Albert Bondt
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.,Department of Rheumatology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.,Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Karli R Reiding
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Emanuela Lonardi
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Coen J de Jong
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - David Falck
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Guinevere S M Kammeijer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Radboud J E M Dolhain
- Department of Rheumatology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
| | - Yoann Rombouts
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.,Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.,Univ. Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, F 59 000 Lille, France
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| |
Collapse
|
22
|
Plomp R, Bondt A, de Haan N, Rombouts Y, Wuhrer M. Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs). Mol Cell Proteomics 2016; 15:2217-28. [PMID: 27009965 PMCID: PMC4937499 DOI: 10.1074/mcp.o116.058503] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2016] [Indexed: 11/06/2022] Open
Abstract
Antibody glycosylation analysis has seen methodological progress resulting in new findings with regard to antibody glycan structure and function in recent years. For example, antigen-specific IgG glycosylation analysis is now applicable for clinical samples because of the increased sensitivity of measurements, and this has led to new insights in the relationship between IgG glycosylation and various diseases. Furthermore, many new methods have been developed for the purification and analysis of IgG Fc glycopeptides, notably multiple reaction monitoring for high-throughput quantitative glycosylation analysis. In addition, new protocols for IgG Fab glycosylation analysis were established revealing autoimmune disease-associated changes. Functional analysis has shown that glycosylation of IgA and IgE is involved in transport across the intestinal epithelium and receptor binding, respectively.
Collapse
Affiliation(s)
- Rosina Plomp
- From the ‡Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands
| | - Albert Bondt
- From the ‡Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands; §Leiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands
| | - Noortje de Haan
- From the ‡Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands
| | - Yoann Rombouts
- ¶Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, France
| | - Manfred Wuhrer
- From the ‡Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands;
| |
Collapse
|
23
|
Cacas JL, Buré C, Grosjean K, Gerbeau-Pissot P, Lherminier J, Rombouts Y, Maes E, Bossard C, Gronnier J, Furt F, Fouillen L, Germain V, Bayer E, Cluzet S, Robert F, Schmitter JM, Deleu M, Lins L, Simon-Plas F, Mongrand S. Revisiting Plant Plasma Membrane Lipids in Tobacco: A Focus on Sphingolipids. Plant Physiol 2016; 170:367-84. [PMID: 26518342 PMCID: PMC4704565 DOI: 10.1104/pp.15.00564] [Citation(s) in RCA: 72] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/16/2015] [Accepted: 10/28/2015] [Indexed: 05/20/2023]
Abstract
The lipid composition of plasma membrane (PM) and the corresponding detergent-insoluble membrane (DIM) fraction were analyzed with a specific focus on highly polar sphingolipids, so-called glycosyl inositol phosphorylceramides (GIPCs). Using tobacco (Nicotiana tabacum) 'Bright Yellow 2' cell suspension and leaves, evidence is provided that GIPCs represent up to 40 mol % of the PM lipids. Comparative analysis of DIMs with the PM showed an enrichment of 2-hydroxylated very-long-chain fatty acid-containing GIPCs and polyglycosylated GIPCs in the DIMs. Purified antibodies raised against these GIPCs were further used for immunogold-electron microscopy strategy, revealing the distribution of polyglycosylated GIPCs in domains of 35 ± 7 nm in the plane of the PM. Biophysical studies also showed strong interactions between GIPCs and sterols and suggested a role for very-long-chain fatty acids in the interdigitation between the two PM-composing monolayers. The ins and outs of lipid asymmetry, raft formation, and interdigitation in plant membrane biology are finally discussed.
Collapse
Affiliation(s)
- Jean-Luc Cacas
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Corinne Buré
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Kevin Grosjean
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Patricia Gerbeau-Pissot
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Jeannine Lherminier
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Yoann Rombouts
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Emmanuel Maes
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Claire Bossard
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Julien Gronnier
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Fabienne Furt
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Laetitia Fouillen
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Véronique Germain
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Emmanuelle Bayer
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Stéphanie Cluzet
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Franck Robert
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Jean-Marie Schmitter
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Magali Deleu
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Laurence Lins
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Françoise Simon-Plas
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| | - Sébastien Mongrand
- Laboratoire de Biogenèse Membranaire, Centre National de la Recherche Scientifique-University of Bordeaux, Unité Mixte de Recherche 5200, F-33883 Villenave d'Ornon cedex, France (J.-L.C., Cl.B., J.G., F.F., L.F., V.G., E.B., S.M.);Chimie Biologie des Membranes et Nanoobjets, Unité Mixte de Recherche 5248, Centre de Génomique Fonctionnelle, Université de Bordeaux, F-33076 Bordeaux cedex, France (Co.B., J.-M.S.);Université de Bourgogne, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.-L.C., K.G., P.G.-P.);Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347 Agroécologie, Equipes de Recherche Labellisée 6300 Centre National de la Recherche Scientifique, F-21065 Dijon cedex, France (J.L., F.R., F.S.-P.);Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8576, F-59655 Villeneuve d'Ascq, France (Y.R., E.M.);Laboratoire de Biophysique Moléculaire aux Interfaces, Université de Liège, B-5030 Gembloux, Belgium (Cl.B., M.D., L.L.); andInstitut des Sciences de la Vigne et du Vin, Groupe d'Etude des Substances Végétales à Activité Biologique, University of Bordeaux, Equipe Associée 3675, F-33400 Talence, France (S.C.)
| |
Collapse
|
24
|
Holst S, Deuss AJM, van Pelt GW, van Vliet SJ, Garcia-Vallejo JJ, Koeleman CAM, Deelder AM, Mesker WE, Tollenaar RA, Rombouts Y, Wuhrer M. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression. Mol Cell Proteomics 2015; 15:124-40. [PMID: 26537799 PMCID: PMC4762531 DOI: 10.1074/mcp.m115.051235] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2015] [Indexed: 01/05/2023] Open
Abstract
Various cancers such as colorectal cancer (CRC) are associated with alterations in protein glycosylation. CRC cell lines are frequently used to study these (glyco)biological changes and their mechanisms. However, differences between CRC cell lines with regard to their glycosylation have hitherto been largely neglected. Here, we comprehensively characterized the N-glycan profiles of 25 different CRC cell lines, derived from primary tumors and metastatic sites, in order to investigate their potential as glycobiological tumor model systems and to reveal glycans associated with cell line phenotypes. We applied an optimized, high-throughput membrane-based enzymatic glycan release for small sample amounts. Released glycans were derivatized to stabilize and differentiate between α2,3- and α2,6-linked N-acetylneuraminic acids, followed by N-glycosylation analysis by MALDI-TOF(/TOF)-MS. Our results showed pronounced differences between the N-glycosylation patterns of CRC cell lines. CRC cell line profiles differed from tissue-derived N-glycan profiles with regard to their high-mannose N-glycan content but showed a large overlap for complex type N-glycans, supporting their use as a glycobiological cancer model system. Importantly, we could show that the high-mannose N-glycans did not only occur as intracellular precursors but were also present at the cell surface. The obtained CRC cell line N-glycan features were not clearly correlated with mRNA expression levels of glycosyltransferases, demonstrating the usefulness of performing the structural analysis of glycans. Finally, correlation of CRC cell line glycosylation features with cancer cell markers and phenotypes revealed an association between highly fucosylated glycans and CDX1 and/or villin mRNA expression that both correlate with cell differentiation. Together, our findings provide new insights into CRC-associated glycan changes and setting the basis for more in-depth experiments on glycan function and regulation.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Yoann Rombouts
- From the ‡Center for Proteomics and Metabolomics, ¶Department of RheumatologyLeiden University Medical Center, Leiden, The Netherlands; ‡‡Univ. Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, F 59 000 Lille, France
| | - Manfred Wuhrer
- From the ‡Center for Proteomics and Metabolomics, ‖Department of Molecular Cell Biology and Immunology and **Division of BioAnalytical Chemistry, VU University Medical Center, Amsterdam, The Netherlands;
| |
Collapse
|
25
|
Dotz V, Haselberg R, Shubhakar A, Kozak RP, Falck D, Rombouts Y, Reusch D, Somsen GW, Fernandes DL, Wuhrer M. Mass spectrometry for glycosylation analysis of biopharmaceuticals. Trends Analyt Chem 2015. [DOI: 10.1016/j.trac.2015.04.024] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
Kempers A, Nejadnik R, Rombouts Y, Jiskoot W, Huizinga T, Toes R, Scherer H. THU0041 Anti-Citrullinated Protein Antibody Binding Profile to Human FC Gamma Receptors. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.5681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
27
|
Kerkman PF, Fabre E, van der Voort EIH, Zaldumbide A, Rombouts Y, Rispens T, Wolbink G, Hoeben RC, Spits H, Baeten DLP, Huizinga TWJ, Toes REM, Scherer HU. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis 2015; 75:1170-6. [DOI: 10.1136/annrheumdis-2014-207182] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2014] [Accepted: 05/10/2015] [Indexed: 11/04/2022]
Abstract
ObjectivesImmunity to citrullinated antigens is a hallmark of rheumatoid arthritis (RA). We set out to elucidate its biology by identifying and characterising citrullinated antigen-specific B cells in peripheral blood of patients with RA.MethodsDifferentially labelled streptavidin and extravidin tetramers were conjugated to biotinylated CCP2 or control antigens and used in flow cytometry to identify citrullinated antigen-specific B cells in peripheral blood. Tetramer-positive and tetramer-negative B cells were isolated by fluorescence activated cell sorting (FACS) followed by in vitro culture and analysis of culture supernatants for the presence of antibodies against citrullinated protein antigens (ACPA) by ELISA. Cells were phenotypically characterised by flow cytometry.ResultsBy combining differentially labelled CCP2 tetramers, we successfully separated citrullinated antigen-specific B cells from non-specific background signals. Isolated tetramer-positive B cells, but not tetramer-negative cells, produced large amounts of ACPA upon in vitro stimulation. Phenotypic analyses revealed that citrullinated antigen-specific B cells displayed markers of class-switched memory B cells and plasmablasts, whereas only few cells displayed a naïve phenotype. The frequency of tetramer-positive cells was high (up to 1/500 memory B cells with a median of 1/12 500 total B cells) and correlated with ACPA serum titres and spontaneous ACPA production in culture.ConclusionsWe developed a technology to identify and isolate citrullinated antigen-specific B cells from peripheral blood of patients with RA. Most cells have a memory phenotype, express IgA or IgG and are present in relatively high frequencies. These data pave the path for a direct and detailed molecular characterisation of ACPA-expressing B cells and could lead to the identification of novel therapeutic targets.
Collapse
|
28
|
Plomp R, Dekkers G, Rombouts Y, Visser R, Koeleman CAM, Kammeijer GSM, Jansen BC, Rispens T, Hensbergen PJ, Vidarsson G, Wuhrer M. Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). Mol Cell Proteomics 2015; 14:1373-84. [PMID: 25759508 PMCID: PMC4424406 DOI: 10.1074/mcp.m114.047381] [Citation(s) in RCA: 74] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2014] [Indexed: 01/18/2023] Open
Abstract
Immunoglobulin G (IgG) is one of the most abundant proteins present in human serum and a fundamental component of the immune system. IgG3 represents ∼8% of the total amount of IgG in human serum and stands out from the other IgG subclasses because of its elongated hinge region and enhanced effector functions. This study reports partial O-glycosylation of the IgG3 hinge region, observed with nanoLC-ESI-IT-MS(/MS) analysis after proteolytic digestion. The repeat regions within the IgG3 hinge were found to be in part O-glycosylated at the threonine in the triple repeat motif. Non-, mono- and disialylated core 1-type O-glycans were detected in various IgG3 samples, both poly- and monoclonal. NanoLC-ESI-IT-MS/MS with electron transfer dissociation fragmentation and CE-MS/MS with CID fragmentation were used to determine the site of IgG3 O-glycosylation. The O-glycosylation site was further confirmed by the recombinant production of mutant IgG3 in which potential O-glycosylation sites had been knocked out. For IgG3 samples from six donors we found similar O-glycan structures and site occupancies, whereas for the same samples the conserved N-glycosylation of the Fc CH2 domain showed considerable interindividual variation. The occupancy of each of the three O-glycosylation sites was found to be ∼10% in six serum-derived IgG3 samples and ∼13% in two monoclonal IgG3 allotypes.
Collapse
Affiliation(s)
- Rosina Plomp
- From the ‡Center for Proteomics and Metabolomics
| | | | - Yoann Rombouts
- From the ‡Center for Proteomics and Metabolomics, §Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
| | | | | | | | - Bas C Jansen
- From the ‡Center for Proteomics and Metabolomics
| | - Theo Rispens
- ¶¶Department of Immunopathology, Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| | | | | | - Manfred Wuhrer
- From the ‡Center for Proteomics and Metabolomics, **Division of BioAnalytical Chemistry, VU University Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
29
|
Rombouts Y, Willemze A, van Beers JJBC, Shi J, Kerkman PF, van Toorn L, Janssen GMC, Zaldumbide A, Hoeben RC, Pruijn GJM, Deelder AM, Wolbink G, Rispens T, van Veelen PA, Huizinga TWJ, Wuhrer M, Trouw LA, Scherer HU, Toes REM. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis. Ann Rheum Dis 2015; 75:578-85. [PMID: 25587188 DOI: 10.1136/annrheumdis-2014-206598] [Citation(s) in RCA: 142] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2014] [Accepted: 12/16/2014] [Indexed: 12/12/2022]
Abstract
OBJECTIVES To understand the molecular features distinguishing anti-citrullinated protein antibodies (ACPA) from 'conventional' antibodies in rheumatoid arthritis (RA). METHODS Serum of ACPA-positive RA patients was fractionated by size exclusion chromatography and analysed for the presence of ACPA-IgG by ELISA. ACPA-IgG and non-citrulline-specific IgG were affinity purified from serum, plasma and/or synovial fluid and analysed by gel electrophoresis. Electrophoresis bands were excised, enzymatically digested and analysed by mass spectrometry. Binding affinity to citrullinated antigens was measured by ELISA and imaging surface plasmon resonance using recombinant monoclonal ACPA with molecular modifications. RESULTS In all donor samples studied (n=24), ACPA-IgG exhibited a 10-20 kDa higher molecular weight compared with non-autoreactive IgG. This feature also distinguished ACPA-IgG from antibodies against recall antigens or other disease-specific autoantibodies. Structural analysis revealed that a high frequency of N-glycans in the (hyper)variable domains of ACPA is responsible for this observation. In line with their localisation, these N-glycans were found to modulate binding avidity of ACPA to citrullinated antigens. CONCLUSIONS The vast majority of ACPA-IgG harbour N-glycans in their variable domains. As N-linked glycosylation requires glycosylation consensus sites in the protein sequence and as these are lacking in the 'germline-counterparts' of identified variable domains, our data indicate that the N-glycosylation sites in ACPA variable domains have been introduced by somatic hypermutation. This finding also suggests that ACPA-hyperglycosylation confers a selective advantage to ACPA-producing B cells. This unique and completely novel feature of the citrulline-specific immune response in RA elucidates our understanding of the underlying B cell response.
Collapse
Affiliation(s)
- Yoann Rombouts
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Annemiek Willemze
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| | - Joyce J B C van Beers
- Radboud Institute for Molecular Life Sciences and Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands
| | - Jing Shi
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| | - Priscilla F Kerkman
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| | - Linda van Toorn
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| | - George M C Janssen
- Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands Netherlands Proteomics Centre, Utrecht, the Netherlands
| | - Arnaud Zaldumbide
- Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands
| | - Rob C Hoeben
- Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands
| | - Ger J M Pruijn
- Radboud Institute for Molecular Life Sciences and Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands
| | - André M Deelder
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Gertjan Wolbink
- Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, the Netherlands Jan van Breemen Research Institute Reade, Amsterdam, the Netherlands
| | - Theo Rispens
- Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, the Netherlands
| | - Peter A van Veelen
- Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands
| | - Tom W J Huizinga
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
| | - Leendert A Trouw
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| | - Hans U Scherer
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| | - René E M Toes
- Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands
| |
Collapse
|
30
|
Abstract
Glycans on proteins and lipids are known to alter with malignant transformation. The study of these may contribute to the discovery of biomarkers and treatment targets as well as understanding of cancer biology. We here describe the change of glycosylation specifically defining colorectal cancer with view on N-glycans, O-glycans, and glycosphingolipid glycans in colorectal cancer cells and tissues as well as patient sera. Glycan alterations observed in colon cancer include increased β1,6-branching and correlating higher abundance of (poly-)N-acetyllactosamine extensions of N-glycans as well as an increase in (truncated) high-mannose type glycans, while bisected structures decrease. Colorectal cancer-associated O-glycan changes are predominated by reduced expression of core 3 and 4 glycans, whereas higher levels of core 1 glycans, (sialyl) T-antigen, (sialyl) Tn-antigen, and a generally higher density of O-glycans are observed. Specific changes for glycosphingolipid glycans are lower abundances of disialylated structures as well as globo-type glycosphingolipid glycans with exception of Gb3. In general, alterations affecting all discussed glycan types are increased sialylation, fucosylation as well as (sialyl) Lewis-type antigens and type-2 chain glycans. As a consequence, interactions with glycan-binding proteins can be affected and the biological function and cellular consequences of the altered glycosylation with regard to tumorigenesis, metastasis, modulation of immunity, and resistance to antitumor therapy will be discussed. Finally, analytical approaches aiding in the field of glycomics will be reviewed with focus on binding assays and mass spectrometry.
Collapse
Affiliation(s)
- Stephanie Holst
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands; Division of BioAnalytical Chemistry, VU University, Amsterdam, The Netherlands
| | - Yoann Rombouts
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands
| |
Collapse
|
31
|
Bondt A, Rombouts Y, Selman MHJ, Hensbergen PJ, Reiding KR, Hazes JMW, Dolhain RJEM, Wuhrer M. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics 2014; 13:3029-39. [PMID: 25004930 PMCID: PMC4223489 DOI: 10.1074/mcp.m114.039537] [Citation(s) in RCA: 189] [Impact Index Per Article: 18.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
The N-linked glycosylation of the constant fragment (Fc) of immunoglobulin G has been shown to change during pathological and physiological events and to strongly influence antibody inflammatory properties. In contrast, little is known about Fab-linked N-glycosylation, carried by ∼ 20% of IgG. Here we present a high-throughput workflow to analyze Fab and Fc glycosylation of polyclonal IgG purified from 5 μl of serum. We were able to detect and quantify 37 different N-glycans by means of MALDI-TOF-MS analysis in reflectron positive mode using a novel linkage-specific derivatization of sialic acid. This method was applied to 174 samples of a pregnancy cohort to reveal Fab glycosylation features and their change with pregnancy. Data analysis revealed marked differences between Fab and Fc glycosylation, especially in the levels of galactosylation and sialylation, incidence of bisecting GlcNAc, and presence of high mannose structures, which were all higher in the Fab portion than the Fc, whereas Fc showed higher levels of fucosylation. Additionally, we observed several changes during pregnancy and after delivery. Fab N-glycan sialylation was increased and bisection was decreased relative to postpartum time points, and nearly complete galactosylation of Fab glycans was observed throughout. Fc glycosylation changes were similar to results described before, with increased galactosylation and sialylation and decreased bisection during pregnancy. We expect that the parallel analysis of IgG Fab and Fc, as set up in this paper, will be important for unraveling roles of these glycans in (auto)immunity, which may be mediated via recognition by human lectins or modulation of antigen binding.
Collapse
Affiliation(s)
- Albert Bondt
- From the ‡Department of Rheumatology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands; §Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
| | - Yoann Rombouts
- §Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; ¶Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
| | - Maurice H J Selman
- §Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
| | - Paul J Hensbergen
- §Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
| | - Karli R Reiding
- §Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
| | - Johanna M W Hazes
- From the ‡Department of Rheumatology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
| | - Radboud J E M Dolhain
- From the ‡Department of Rheumatology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
| | - Manfred Wuhrer
- §Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; ‖Division of BioAnalytical Chemistry, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands; **Department of Molecular Cell Biology and Immunology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
| |
Collapse
|
32
|
Scherer H, Rombouts Y, Willemze A, van Beers J, Shi J, Kerkman P, Janssen G, van Veelen P, Zaldumbide A, Hoeben R, Pruijn G, Deelder A, Wolbink GJ, Rispens T, Huizinga T, Wuhrer M, Trouw L, Toes R. OP0177 A High Frequency of N-Glycans in the Acpa-Igg Variable Domain Modulates Reactivity to Citrullinated Antigens. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.4717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
33
|
Rombouts Y, Willemze A, van Beers JJBC, Shi J, Kerkman PF, Janssen GMC, van Veelen PA, Zaldumbide A, Hoeben RC, Pruijn GJ, Deelder AM, Wolbink G, Rispens T, García-Vallejo JJ, van Kooyk Y, Huizinga TWJ, Wuhrer M, Trouw LA, Scherer HU, Toes REM. A1.45 Hyperglycosylation of ACPA-IGG variable domains modulates reactivity to citrullinated antigens. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-205124.44] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
34
|
Bondt A, Rombouts Y, Hazes JMW, Wuhrer M, Dolhain RJEM. A1.2 High Throughput analysis of IGG fab glycosylation reveals differences between RA-patients and healthy controls during pregnancy and after delivery. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-205124.2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CAM, Deelder AM, Wuhrer M. Site-Specific N-Glycosylation Analysis of Human Immunoglobulin E. J Proteome Res 2013; 13:536-46. [DOI: 10.1021/pr400714w] [Citation(s) in RCA: 73] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
| | | | | | | | | | | | | | - Manfred Wuhrer
- Division of BioAnalytical Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| |
Collapse
|
36
|
Alibaud L, Pawelczyk J, Gannoun-Zaki L, Singh VK, Rombouts Y, Drancourt M, Dziadek J, Guérardel Y, Kremer L. Increased phagocytosis of Mycobacterium marinum mutants defective in lipooligosaccharide production: a structure-activity relationship study. J Biol Chem 2013; 289:215-28. [PMID: 24235141 DOI: 10.1074/jbc.m113.525550] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Mycobacterium marinum is a waterborne pathogen responsible for tuberculosis-like infections in ectotherms and is an occasional opportunistic human pathogen. In the environment, M. marinum also interacts with amoebae, which may serve as a natural reservoir for this microorganism. However, the description of mycobacterial determinants in the early interaction with macrophages or amoebae remains elusive. Lipooligosaccharides (LOSs) are cell surface-exposed glycolipids capable of modulating the host immune system, suggesting that they may be involved in the early interactions of M. marinum with macrophages. Herein, we addressed whether LOS composition affects the uptake of M. marinum by professional phagocytes. Mutants with various truncated LOS variants were generated, leading to the identification of several previously uncharacterized biosynthetic genes (wbbL2, MMAR_2321, and MMAR_2331). Biochemical and structural approaches allowed resolving the structures of LOS precursors accumulating in this set of mutants. These strains with structurally defined LOS profiles were then used to infect both macrophages and Acanthamoebae. An inverse correlation between LOS completeness and uptake of mycobacteria by phagocytes was found, allowing the proposal of three mutant classes: class I (papA4), devoid of LOS and highly efficiently phagocytosed; class II, accumulating only early LOS intermediates (wbbL2 and MMAR_2331) and efficiently phagocytosed but less than class I mutants; class III, lacking LOS-IV (losA, MMAR_2319, and MMAR_2321) and phagocytosed similarly to the control strain. These results indicate that phagocytosis is conditioned by the LOS pattern and that the LOS pathway used by M. marinum in macrophages is conserved during infection of amoebae.
Collapse
Affiliation(s)
- Laeticia Alibaud
- From the Laboratoire de Dynamique des Interactions Membranaires Normales et Pathologiques, Université de Montpellier 2 et 1, CNRS, UMR 5235, case 107, Place Eugène Bataillon, 34095 Montpellier Cedex 05, France
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Rombouts Y, Ewing E, van de Stadt LA, Selman MHJ, Trouw LA, Deelder AM, Huizinga TWJ, Wuhrer M, van Schaardenburg D, Toes REM, Scherer HU. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis 2013; 74:234-41. [PMID: 24106048 DOI: 10.1136/annrheumdis-2013-203565] [Citation(s) in RCA: 190] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To determine whether anticitrullinated protein antibodies (ACPA) exhibit specific changes in Fc glycosylation prior to the onset of arthritis. METHODS Serum samples of patients with ACPA-positive arthralgia (n=183) were collected at baseline and at various time points of follow-up. 105 patients developed arthritis after a median of 12 months (IQR 6-24) and were classified as having either rheumatoid arthritis (RA, n=48) or undifferentiated arthritis (UA, n=57) based on the 1987 American College of Rheumatology (ACR) criteria. ACPA and total serum IgG were isolated by affinity purification and cleaved by trypsin. ACPA-IgG1 Fc-glycopeptides were subsequently analysed by nano-liquid chromatography mass spectrometry and compared to those of total IgG1. RESULTS At baseline, ACPA-IgG1 and total IgG1 from arthralgia patients displayed similar Fc glycosylation patterns. By contrast, at the onset of arthritis, ACPA exhibited a decrease in galactose residues in RA patients, but not in UA patients. This decrease occurred around 3 months prior to diagnosis and was paralleled by an increase in systemic inflammation (erythrocyte sedimentation rate). Galactosylation of total IgG1 was also decreased in RA, but this did not precede the onset of arthritis. Interestingly, we additionally noted a higher degree of ACPA-IgG1 Fc core fucosylation at baseline as compared with total IgG1, which further increased prior to diagnosis. CONCLUSIONS ACPA display significant changes in Fc galactosylation and fucosylation prior to the onset of RA. These changes towards a more pro-inflammatory phenotype could be involved in driving the disease process.
Collapse
Affiliation(s)
- Yoann Rombouts
- Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Ewoud Ewing
- Center for Proteomics and Metabolomics, Leiden University Medical Centre, Leiden, The Netherlands
| | | | - Maurice H J Selman
- Center for Proteomics and Metabolomics, Leiden University Medical Centre, Leiden, The Netherlands
| | - Leendert A Trouw
- Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - André M Deelder
- Center for Proteomics and Metabolomics, Leiden University Medical Centre, Leiden, The Netherlands
| | - Tom W J Huizinga
- Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Centre, Leiden, The Netherlands
| | - Dirkjan van Schaardenburg
- Jan van Breemen Research Institute
- Reade, Amsterdam, The Netherlands Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
| | - René E M Toes
- Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Hans U Scherer
- Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
| |
Collapse
|
38
|
Scherer HU, Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Deelder AM, Huizinga TW, Wuhrer M, van Schaardenburg D, Toes RE. OP0189 Anti-Citrullinated Protein Antibody Specific FC Glycosylation Patterns in Patients with Arthralgia. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
39
|
Kerkman PF, Rombouts Y, van der Voort EIH, Trouw LA, Huizinga TWJ, Toes REM, Scherer HU. Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis. Ann Rheum Dis 2013; 72:1259-63. [DOI: 10.1136/annrheumdis-2012-202893] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
ObjectiveTo study the characteristics and phenotype of anticitrullinated protein antibody (ACPA)-specific B cells in peripheral blood of patients with rheumatoid arthritis (RA).MethodsPeripheral blood B cells from ACPA-positive patients with RA were cultured with or without stimulating factors. Following culture, supernatants were assessed for the presence of ACPA-IgG and non-specific total IgG by ELISA.ResultsFollowing stimulation, ACPA were detectable in up to 100% of culture wells. Of interest, ACPA were also produced spontaneously by unstimulated peripheral blood mononuclear cells. In both cases, the average ACPA titre per culture well correlated with ACPA serum titres. No ACPA production was detectable in B cell cultures from ACPA-negative patients with RA or healthy controls. Importantly, FACS-sorting experiments located spontaneous ACPA production to the CD20 negative B cell population corresponding to circulating plasmablasts/cells.ConclusionsACPA-specific peripheral blood B cells are not confined to the CD20 positive memory pool, as circulating plasmablasts/cells spontaneously producing ACPA are also readily detectable. The latter points to an ongoing B cell immune response against citrullinated proteins and contrasts conventional immune responses against, for example, vaccines, where antigen-specific plasmablasts appear in peripheral blood only shortly after vaccination. These circulating, ACPA-specific plasmablasts/cells might represent targets for novel therapeutic interventions.
Collapse
|
40
|
Ioan-Facsinay A, Kwekkeboom JC, Westhoff S, Giera M, Rombouts Y, van Harmelen V, Huizinga TWJ, Deelder A, Kloppenburg M, Toes REM. Adipocyte-derived lipids modulate CD4+ T-cell function. Eur J Immunol 2013; 43:1578-87. [PMID: 23504601 DOI: 10.1002/eji.201243096] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2012] [Revised: 02/08/2013] [Accepted: 03/08/2013] [Indexed: 11/09/2022]
Abstract
Adipose tissue contains several immune cells whose number and phenotype vary depending on the adiposity. In the present study, we show that IFN-γ(+) CD4(+) T cells are enriched in human adipose tissue compared with in blood. To gain insight into the underlying mechanisms, we investigated the possibility that human adipocytes modulate CD4(+) T-cell cytokine production and proliferation and show that CD4(+) T cells produced increased levels of IFN-γ when activated in the presence of adipocytes. This effect was mediated by soluble mediators, as shown in transwell and adipocyte-conditioned medium (ACM) transfer experiments. Additionally, ACM induced increased proliferation of CD4(+) T cells upon activation. Intriguingly, the proliferation-enhancing effect resided mainly in the lipid fraction of ACM, as shown upon separation of the protein and lipid fraction. Further separation of these lipids based on polarity revealed that the modulatory effect is confined to fractions containing free fatty acids. All identified fatty acids were able to individually enhance T-cell proliferation. These data indicate that adipocytes can modulate CD4(+) T-cell function through the release of lipids. Remarkably, free fatty acids were the most prominent modulators of T-cell proliferation, possibly leading to an accumulation of these cells in adipose tissue.
Collapse
Affiliation(s)
- Andreea Ioan-Facsinay
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Kempers AC, Scherer HU, Rombouts Y, Ewing E, Stadt LAVD, Selman MHJ, Deelder AM, Huizinga TWJ, Wuhrer M, Schaardenburg DV, Toes REM. A1.1 Anti-Citrullinated Protein Antibody Specific Fc Glycosylation Patterns in Arthralgia Patients. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-203214.1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
42
|
Ioan-Facsinay A, Kwekkeboom JC, Westhoff S, Giera M, Rombouts Y, Huizinga TWJ, Deelder A, Kloppenburg M, Toes REM. A4.2 Adipocytes Modulate T Cell Function through Release of Lipids. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-203217.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
43
|
Kerkman PF, Rombouts Y, Voort EIHVD, Trouw LA, Huizinga TWJ, Toes REM, Scherer HU. A5.29 Spontaneous Production of Anti-Citrullinated Protein Antibodies in Cultures of Peripheral Blood Mononuclear Cells and Synovial Fluid Mononuclear Cells Isolated from Patients with Rheumatoid Arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-203219.29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
44
|
Abstract
Antibody glycosylation has been shown to change with various processes. This review presents mass spectrometric approaches for antibody glycosylation analysis at the level of released glycans, glycopeptides, and intact protein. With regard to IgG fragment crystallizable glycosylation, mass spectrometry has shown its potential for subclass-specific, high-throughput analysis. In contrast, because of the vast heterogeneity of peptide moieties, fragment antigen binding glycosylation analysis of polyclonal IgG relies entirely on glycan release. Next to IgG, IgA has gained some attention, and studies of its O- and N-glycosylation have revealed disease-associated glycosylation changes. Glycoproteomic analyses of IgM and IgE are lagging behind but should complete our picture of glycosylation's influence on antibody function.
Collapse
Affiliation(s)
- Gerhild Zauner
- Biomolecular Mass Spectrometry Unit, Postbus 9600, 2300RC Leiden University Medical Center, Leiden, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
45
|
Coddeville B, Wu SW, Fabre E, Brassart C, Rombouts Y, Burguière A, Kremer L, Khoo KH, Elass-Rochard E, Guérardel Y. Identification of the Mycobacterium marinum Apa antigen O-mannosylation sites reveals important glycosylation variability with the M. tuberculosis Apa homologue. J Proteomics 2012; 75:5695-705. [PMID: 22828516 DOI: 10.1016/j.jprot.2012.07.017] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2012] [Revised: 06/28/2012] [Accepted: 07/12/2012] [Indexed: 01/22/2023]
Abstract
The 45/47 kDa Apa, an immuno-dominant antigen secreted by Mycobacterium tuberculosis is O-mannosylated at multiple sites. Glycosylation of Apa plays a key role in colonization and invasion of the host cells by M. tuberculosis through interactions of Apa with the host immune system C-type lectins. Mycobacterium marinum (M.ma) a fish pathogen, phylogenetically close to M. tuberculosis, induces a granulomatous response with features similar to those described for M. tuberculosis in human. Although M.ma possesses an Apa homologue, its glycosylation status is unknown, and whether this represents a crucial element in the pathophysiology induced by M.ma remains to be addressed. To this aim, we have identified two concanavalin A-reactive 45/47 kDa proteins from M.ma, which have been further purified by a two-step anion exchange chromatography process. Advanced liquid chromatography-nanoESI mass spectrometry-based proteomic analyses of peptides, derived from either tryptic digestion alone or in combination with the Asp-N endoproteinase, established that M.ma Apa possesses up to seven distinct O-mannosylated sites with mainly single mannose substitutions, which can be further extended at the Ser/Thr/Pro rich region near the N-terminus. This opens the way to further studies focussing on the involvement and biological functions of Apa O-mannosylation using the M.ma/zebrafish model.
Collapse
Affiliation(s)
- Bernadette Coddeville
- Université Lille1, Unité de Glycobiologie Structurale et Fonctionnelle, UGSF, F-59650 Villeneuve d'Ascq, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Elass-Rochard E, Rombouts Y, Coddeville B, Maes E, Blervaque R, Hot D, Kremer L, Guérardel Y. Structural determination and Toll-like receptor 2-dependent proinflammatory activity of dimycolyl-diarabino-glycerol from Mycobacterium marinum. J Biol Chem 2012; 287:34432-44. [PMID: 22798072 DOI: 10.1074/jbc.m112.378083] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Although it was identified in the cell wall of several pathogenic mycobacteria, the biological properties of dimycolyl-diarabino-glycerol have not been documented yet. In this study an apolar glycolipid, presumably corresponding to dimycolyl-diarabino-glycerol, was purified from Mycobacterium marinum and subsequently identified as a 5-O-mycolyl-β-Araf-(1→2)-5-O-mycolyl-α-Araf-(1→1')-glycerol (designated Mma_DMAG) using a combination of nuclear magnetic resonance spectroscopy and mass spectrometry analyses. Lipid composition analysis revealed that mycolic acids were dominated by oxygenated mycolates over α-mycolates and devoid of trans-cyclopropane functions. Highly purified Mma_DMAG was used to demonstrate its immunomodulatory activity. Mma_DMAG was found to induce the secretion of proinflammatory cytokines (TNF-α, IL-8, IL-1β) in human macrophage THP-1 cells and to trigger the expression of ICAM-1 and CD40 cell surface antigens. This activation mechanism was dependent on TLR2, but not on TLR4, as demonstrated by (i) the use of neutralizing anti-TLR2 and -TLR4 antibodies and by (ii) the detection of secreted alkaline phosphatase in HEK293 cells co-transfected with the human TLR2 and secreted embryonic alkaline phosphatase reporter genes. In addition, transcriptomic analyses indicated that various genes encoding proinflammatory factors were up-regulated after exposure of THP-1 cells to Mma_DMAG. Importantly, a wealth of other regulated genes related to immune and inflammatory responses, including chemokines/cytokines and their respective receptors, adhesion molecules, and metalloproteinases, were found to be modulated by Mma_DMAG. Overall, this study suggests that DMAG may be an active cell wall glycoconjugate driving host-pathogen interactions and participating in the immunopathogenesis of mycobacterial infections.
Collapse
Affiliation(s)
- Elisabeth Elass-Rochard
- Université Lille Nord de France, Université Lille1, Unité de Glycobiologie Structurale et Fonctionnelle, UGSF, IFR 147, France.
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Rombouts Y, Brust B, Ojha AK, Maes E, Coddeville B, Elass-Rochard E, Kremer L, Guerardel Y. Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism. J Biol Chem 2012; 287:11060-9. [PMID: 22315220 DOI: 10.1074/jbc.m111.327387] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The "cell wall core" consisting of a mycolyl-arabinogalactan-peptidoglycan (mAGP) complex represents the hallmark of the mycobacterial cell envelope. It has been the focus of intense research at both structural and biosynthetic levels during the past few decades. Because it is essential, mAGP is also regarded as a target for several antitubercular drugs. Herein, we demonstrate that exposure of Mycobacterium bovis Bacille Calmette-Guérin or Mycobacterium marinum to thiacetazone, a second line antitubercular drug, is associated with a severe decrease in the level of a major apolar glycolipid. This inhibition requires MmaA4, a methyltransferase reported to participate in the activation process of thiacetazone. Following purification, this glycolipid was subjected to detailed structural analyses, combining gas-liquid chromatography, mass spectrometry, and nuclear magnetic resonance. This allowed to identify it as a 5-O-mycolyl-β-Araf-(1→2)-5-O-mycolyl-α-Araf-(1→1)-Gro, designated dimycolyl diarabinoglycerol (DMAG). The presence of DMAG was subsequently confirmed in other slow growing pathogenic species, including Mycobacterium tuberculosis. DMAG production was stimulated in the presence of exogenous glycerol. Interestingly, DMAG appears structurally identical to the terminal portion of the mycolylated arabinosyl motif of mAGP, and the metabolic relationship between these two components was provided using antitubercular drugs such as ethambutol or isoniazid known to inhibit the biosynthesis of arabinogalactan or mycolic acid, respectively. Finally, DMAG was identified in the cell wall of M. tuberculosis. This opens the possibility of a potent biological function for DMAG that may be important to mycobacterial pathogenesis.
Collapse
Affiliation(s)
- Yoann Rombouts
- Université Lille Nord de France, Université Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle (UGSF), F-59650 Villeneuve d'Ascq, France
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Cazet A, Bobowski M, Rombouts Y, Lefebvre J, Steenackers A, Popa I, Guérardel Y, Le Bourhis X, Tulasne D, Delannoy P. The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase. Glycobiology 2012; 22:806-16. [PMID: 22301273 DOI: 10.1093/glycob/cws049] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
We have recently established and characterized cellular clones deriving from MDA-MB-231 breast cancer cells that express the human G(D3) synthase (GD3S), the enzyme that controls the biosynthesis of b- and c-series gangliosides. The GD3S positive clones show a proliferative phenotype in the absence of serum or growth factors and an increased tumor growth in severe immunodeficient mice. This phenotype results from the constitutive activation of the receptor tyrosine kinase c-Met in spite of the absence of ligand and subsequent activation of mitogen-activated protein kinase/extracellular signal-regulated kinase and phosphoinositide 3-kinase/Akt pathways. Here, we show by mass spectrometry analysis of total glycosphingolipids that G(D3) and G(D2) are the main gangliosides expressed by the GD3S positive clones. Moreover, G(D2) colocalized with c-Met at the plasma membrane and small interfering RNA silencing of the G(M2)/G(D2) synthase efficiently reduced the expression of G(D2) as well as c-Met phosphorylation and reversed the proliferative phenotype. Competition assays using anti-G(D2) monoclonal antibodies also inhibit proliferation and c-Met phosphorylation of GD3S positive clones in serum-free conditions. Altogether, these results demonstrate the involvement of the disialoganglioside G(D2) in MDA-MB-231 cell proliferation via the constitutive activation of c-Met. The accumulation of G(D2) in c-Met expressing cells could therefore reinforce the tumorigenicity and aggressiveness of breast cancer tumors.
Collapse
Affiliation(s)
- Aurélie Cazet
- Université Lille Nord de France, F-59000 Lille, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Steenackers A, Cazet A, Bobowski M, Rombouts Y, Lefebvre J, Guérardel Y, Tulasne D, Le Bourhis X, Delannoy P. Expression of GD3 synthase modifies ganglioside profile and increases migration of MCF-7 breast cancer cells. CR CHIM 2012. [DOI: 10.1016/j.crci.2011.05.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
50
|
Rombouts Y, Alibaud L, Carrère-Kremer S, Maes E, Tokarski C, Elass E, Kremer L, Guérardel Y. Fatty acyl chains of Mycobacterium marinum lipooligosaccharides: structure, localization and acylation by PapA4 (MMAR_2343) protein. J Biol Chem 2011; 286:33678-88. [PMID: 21803773 DOI: 10.1074/jbc.m111.273920] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
We have recently established the fine structure of the glycan backbone of lipooligosaccharides (LOS-I to LOS-IV) isolated from Mycobacterium marinum, a close relative of Mycobacterium tuberculosis. These studies culminated with the description of an unusual terminal N-acylated monosaccharide that confers important biological functions to LOS-IV, such as macrophage activation, that may be relevant to granuloma formation. It was, however, also suggested that the lipid moiety was required for LOSs to exert their immunomodulatory activity. Herein, using highly purified LOSs from M. marinum, we have determined through a combination of mass spectrometric and NMR techniques, the structure and localization of the fatty acids composing the lipid moiety. The occurrence of two distinct polymethyl-branched fatty acids presenting specific localizations is consistent with the presence of two highly related polyketide synthases (Pks5 and Pks5.1) in M. marinum and presumably involved in the synthesis of these fatty acyl chains. In addition, a bioinformatic search permitted us to identify a set of enzymes potentially involved in the biosynthesis or transfer of these lipids to the LOS trehalose unit. These include MMAR_2343, a member of the Pap (polyketide-associated protein) family, that acylates trehalose-based glycolipids in M. marinum. The participation of MMAR_2343 to LOS assembly was demonstrated using a M. marinum mutant carrying a transposon insertion in the MMAR_2343 gene. Disruption of MMAR_2343 resulted in a severe LOS breakdown, indicating that MMAR_2343, hereafter designated PapA4, fulfills the requirements for LOS acylation and assembly.
Collapse
Affiliation(s)
- Yoann Rombouts
- Université de Lille 1, Unité de Glycobiologie Structurale et Fonctionnelle, F-59650 Villeneuve d'Ascq, France
| | | | | | | | | | | | | | | |
Collapse
|